IceCure Medical (ICCM) Receivables - Net (2020 - 2025)
IceCure Medical (ICCM) has disclosed Receivables - Net for 5 consecutive years, with $221000.0 as the latest value for Q4 2024.
- On a quarterly basis, Receivables - Net rose 114.56% to $221000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $221000.0, a 114.56% increase, with the full-year FY2024 number at $221000.0, up 114.56% from a year prior.
- Receivables - Net was $221000.0 for Q4 2024 at IceCure Medical, up from $103000.0 in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $221000.0 in Q4 2024 to a low of $78000.0 in Q4 2022.
- A 5-year average of $118000.0 and a median of $94000.0 in 2020 define the central range for Receivables - Net.
- Peak YoY movement for Receivables - Net: dropped 17.02% in 2022, then soared 114.56% in 2024.
- IceCure Medical's Receivables - Net stood at $94000.0 in 2020, then changed by 0.0% to $94000.0 in 2021, then fell by 17.02% to $78000.0 in 2022, then soared by 32.05% to $103000.0 in 2023, then skyrocketed by 114.56% to $221000.0 in 2024.
- Per Business Quant, the three most recent readings for ICCM's Receivables - Net are $221000.0 (Q4 2024), $103000.0 (Q4 2023), and $78000.0 (Q4 2022).